Viridian Therapeutics Ors Inc (VRDN)
SG&A Expense Growth
42.13%
Quarterly · Period ending:
VRDN SG&A Expense Growth
Latest reported42.13%period ending
Latest reported42.13%period ending
VRDN Quarterly SG&A Growth (QoQ) (0.00% → 42.13%)
Latest values, visible window
High-resolution chart · PNG
VRDN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 42.1314% | |
| 14.8631% | |
| 38.4508% | |
| 20.3106% | |
| 18.2015% | |
| 9.7472% | |
| 8.1621% | |
| -10.3199% | |
| 6.9285% | |
| -54.46% | |
| 57.7782% | |
| 8.5496% | |
| -11.7585% | |
| 121.5446% | |
| 11.2064% | |
| 9.2871% | |
| -3.0028% | |
| 21.1274% | |
| 10.9307% | |
| -4.6298% | |
| 5.8929% | |
| 11.2516% | |
| 140.8438% | |
| -15.0407% | |
| -0.6243% | |
| 7.4586% | |
| -12.5604% | |
| 1.4351% | |
| -14.8943% | |
| 24.564% | |
| -0.0371% | |
| 1.0495% | |
| -10.7692% | |
| 17.3469% | |
| 1.8385% | |
| -3.0608% | |
| -21.335% | |
| 22.3341% | |
| 42.6596% | |
| -21.5359% | |
| -8.4448% | |
| -3.2175% | |
| -3.3941% | |
| 19.0051% | |
| -1.8773% | |
| 22.5529% | |
| -1.5311% | |
| -41.5828% | |
| 480.8394% | |
| -25.1663% | |
| 46.0958% | |
| -0.3645% | |
| 6.6424% | |
| 0% |